Related Experiment Videos
The bone marrow in murine AIDS
1Istituto di Chimica Biologica G. Fornaini, Università degli Studi di Urbino, Italy.
Abstract:
In order to increase the understanding of blood cytopenias in HIV infection we have investigated the bone marrow in murine AIDS. C57BL/6 mice infected with the LP-BM5 retrovirus show a decrease in cellularity, numerous haemophagocytic histiocytes, a reduction of all erythroid precursor cells, an increase in eosinophil number and an increase in lymphocytes. Immunostaining with an anti-Pr60gag antibody shows that the majority of bone marrow cells express the viral protein. Thus, the bone marrow in MAIDS has many similarities with the bone marrow from patients with advanced AIDS and may prove useful as a model for therapy aimed at treating blood cytopenias.
Insights
Murine AIDS (MAIDS) bone marrow shows reduced cellularity and erythroid precursors, with increased eosinophils and lymphocytes. This MAIDS model mirrors human advanced AIDS bone marrow, aiding blood cytopenias research.
Area of Science:
- Immunology
- Hematology
- Virology
Background:
- Blood cytopenias are common in HIV infection.
- Understanding bone marrow changes in HIV is crucial for treatment.
- Murine models offer insights into human diseases.
Purpose of the Study:
- To investigate bone marrow alterations in murine AIDS (MAIDS).
- To assess the utility of MAIDS as a model for HIV-related blood cytopenias.
Main Methods:
- C57BL/6 mice were infected with the LP-BM5 retrovirus to induce MAIDS.
- Bone marrow cellularity and cell populations were analyzed.
- Immunostaining with an anti-Pr60gag antibody was performed.
Main Results:
- MAIDS bone marrow exhibited decreased cellularity and erythroid precursor cells.
- Increased numbers of haemophagocytic histiocytes, eosinophils, and lymphocytes were observed.
- Viral protein expression was detected in the majority of bone marrow cells.
Conclusions:
- MAIDS bone marrow shares similarities with human advanced AIDS bone marrow.
- The MAIDS model is valuable for studying and treating HIV-associated blood cytopenias.